![alnylam pharmaceuticals glp-1 receptor agonist Protection against stroke with glucagon-like peptide-1 agonists: a comprehensive review of potential mechanisms | Cardiovascular Diabetology glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12933-022-01686-3/MediaObjects/12933_2022_1686_Fig1_HTML.png)
alnylam pharmaceuticals glp-1 receptor agonist Protection against stroke with glucagon-like peptide-1 agonists: a comprehensive review of potential mechanisms | Cardiovascular Diabetology glp-1_analogs [TUSOM | Pharmwiki]
USD22.89
USD69.89
Pay in 4 interest-free payments of $5.72 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
![alnylam pharmaceuticals glp-1 receptor agonist Protection against stroke with glucagon-like peptide-1 agonists: a comprehensive review of potential mechanisms | Cardiovascular Diabetology glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
![alnylam pharmaceuticals glp-1 receptor agonist Protection against stroke with glucagon-like peptide-1 agonists: a comprehensive review of potential mechanisms | Cardiovascular Diabetology glp-1_analogs [TUSOM | Pharmwiki]](https://img.medscapestatic.com/vim/live/professional_assets/medscape/Infographics/glps-and-heart-timeline.png)
![alnylam pharmaceuticals glp-1 receptor agonist Protection against stroke with glucagon-like peptide-1 agonists: a comprehensive review of potential mechanisms | Cardiovascular Diabetology glp-1_analogs [TUSOM | Pharmwiki]](https://www.cardionerds.com/wp-content/uploads/2024/05/Clinical-Implementation-of-GLP-1-Receptor-Agonists-with-Dr.-Neha-Pagidapati-2.png)
![alnylam pharmaceuticals glp-1 receptor agonist Protection against stroke with glucagon-like peptide-1 agonists: a comprehensive review of potential mechanisms | Cardiovascular Diabetology glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs41030-022-00203-x/MediaObjects/41030_2022_203_Fig1_HTML.png)
![alnylam pharmaceuticals glp-1 receptor agonist Protection against stroke with glucagon-like peptide-1 agonists: a comprehensive review of potential mechanisms | Cardiovascular Diabetology glp-1_analogs [TUSOM | Pharmwiki]](https://www.thelancet.com/cms/10.1016/S0140-6736(25)02105-1/asset/b32ab9d0-e386-442b-aa33-27809ce3bc3c/main.assets/gr3_lrg.jpg)
